Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX7XCV
|
||||
| Drug Name |
2-Biphenyl-3-yl-4-methyl-pentanoic acid cyanomethyl-amide
|
||||
| Synonyms |
CHEMBL122764
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H22N2O
|
||||
| Canonical SMILES |
CC(C)CC(C(=O)NCC#N)c1cccc(c1)c2ccccc2
|
||||
| InChI |
InChI=1S/C20H22N2O/c1-15(2)13-19(20(23)22-12-11-21)18-10-6-9-17(14-18)16-7-4-3-5-8-16/h3-10,14-15,19H,12-13H2,1-2H3,(H,22,23)
|
||||
| InChIKey |
BNUJXKLKLWZLCQ-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.